News
NTRBW
1.120
0.00%
0.00
Weekly Report: what happened at NTRB last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at NTRB last week (0427-0501)?
Weekly Report · 05/04 10:37
Nutriband FY26 net loss narrows to $8.23 million; revenue slips to $2.04 million
PUBT · 04/29 21:39
Weekly Report: what happened at NTRB last week (0420-0424)?
Weekly Report · 04/27 10:41
Nutriband CEO Sheridan discusses fentanyl crisis, AVERSA technology on Jack Neel Podcast
PUBT · 04/22 11:05
Weekly Report: what happened at NTRB last week (0413-0417)?
Weekly Report · 04/20 10:36
Weekly Report: what happened at NTRB last week (0406-0410)?
Weekly Report · 04/13 10:41
Nutriband Advances Lead Abuse-Deterrent Fentanyl Patch Branding
TipRanks · 04/07 19:58
Nutriband submits proposed brand name for abuse-deterrent fentanyl patch to FDA for review
Reuters · 04/07 19:44
Analysts Offer Insights on Healthcare Companies: Roche Holding (OtherRHHBY), Nutriband (NTRB) and REPRO-MED Systems (KRMD)
TipRanks · 04/06 13:20
Weekly Report: what happened at NTRB last week (0330-0403)?
Weekly Report · 04/06 10:41
Nutriband Selects Commercial Brand Name For Abuse-Deterrent Fentanyl Patch; Prepares FDA And Global Trademark Submissions
Benzinga · 03/30 20:18
Nutriband submits fentanyl patch brand name, labeling to FDA for review
Reuters · 03/30 20:12
NUTRIBAND INC - SELECTED NAME SUBMITTED TO US PATENT AND TRADEMARK OFFICE FOR REGISTRATION
Reuters · 03/30 20:06
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Barchart · 03/30 15:05
Weekly Report: what happened at NTRB last week (0323-0327)?
Weekly Report · 03/30 10:42
Weekly Report: what happened at NTRB last week (0316-0320)?
Weekly Report · 03/23 10:37
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 03/20 17:06
Nutriband’s Kinesiology Tapes approved for distribution and sale in Costa Rica
TipRanks · 03/18 11:16
Nutriband Gets Approval To Sell Kinesiology Tapes In Costa Rica
Benzinga · 03/18 11:08
More
Webull provides a variety of real-time NTRBW stock news. You can receive the latest news about Nutriband through multiple platforms. This information may help you make smarter investment decisions.
About NTRBW
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.